Prominent angiopathologic events associated with hypertrophy and ischemia are accompanied by secretion of growth factors from reactive cells. The maintenance of endothelial integrity includes the responsibility of acidic fibroblast growth factor (FGF-1), an angiogenic polypeptide lacking a classical signal sequence for secretion. Recent evidence from this laboratory has defined a nonconventional pathway for cellular secretion of FGF-1 that is induced by oxidative stress associated with inflammation and mediated by superoxide, nitric oxide, and their reaction product, peroxynitrite. During this process, FGF-1 modulates the induction of oxidant-mediated apoptosis, an observation accompanied by the appearance of select polypeptides containing nitrated tyrosine residues. Collectively, these observations imply a central role for FGF-1 during resolution of inflammation and repair. Experimental aims are designed within the framework of the hypothesis that in response to oxidative stress, FGF-1 mediates its transforming potential through an extracellular pathway which can be attenuated with specific antioxidant agents. An underlying theme includes quantitating the production and targeted molecular responses to reactive nitrogen/oxygen species in vitro that modulate antioxidant defense mechanisms and FGF-1 signal transduction pathways. The availability of antibodies, nucleic acid probes/amplimers, recombinant proteins, expression vectors, and established techniques permits fundamental mechanistic studies of responding molecular cascades by analyses of mRNA (RT-PCR, hybridization) and protein (Western, ELISA, immunohistochemistry, enzymatic activity) expression. The opportunity to dissect and modulate key FGF-1 and oxidant-induced responses in defined vascular cells is complemented by the ability to extend these observations into relevant rodent models of hypertrophy and ischemia reperfusion injury. Elucidation of the molecular events responsible for the cause and effect relationship between oxidant stress and FGF-1 secretion and biologic activity will reveal detailed characteristics of these interrelationships, provide diagnostic criteria for monitoring this process, and establish more rational strategies of therapeutic intervention.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
2R01HL045990-06
Application #
2461718
Study Section
Pathology A Study Section (PTHA)
Program Officer
Freeman, Colette S
Project Start
1993-02-01
Project End
2002-03-31
Budget Start
1998-04-01
Budget End
1999-03-31
Support Year
6
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Alabama Birmingham
Department
Surgery
Type
Schools of Medicine
DUNS #
004514360
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Olave, Nelida; Nicola, Teodora; Zhang, Wei et al. (2012) Transforming growth factor-? regulates endothelin-1 signaling in the newborn mouse lung during hypoxia exposure. Am J Physiol Lung Cell Mol Physiol 302:L857-65
Ambalavanan, Namasivayam; Nicola, Teodora; Hagood, James et al. (2008) Transforming growth factor-beta signaling mediates hypoxia-induced pulmonary arterial remodeling and inhibition of alveolar development in newborn mouse lung. Am J Physiol Lung Cell Mol Physiol 295:L86-95
Ambalavanan, Namasivayam; Nicola, Teodora; Li, Peng et al. (2008) Role of matrix metalloproteinase-2 in newborn mouse lungs under hypoxic conditions. Pediatr Res 63:26-32
Ambalavanan, Namasivayam; Li, Peng; Bulger, Arlene et al. (2007) Endothelin-1 mediates hypoxia-induced increases in vascular collagen in the newborn mouse lung. Pediatr Res 61:559-64
Zhang, Pei; Greendorfer, Jessica S; Jiao, Jing et al. (2006) Alternatively spliced FGFR-1 isoforms differentially modulate endothelial cell activation of c-YES. Arch Biochem Biophys 450:50-62
Chen, Yiu-Fai; Feng, Ji-An; Li, Peng et al. (2006) Dominant negative mutation of the TGF-beta receptor blocks hypoxia-induced pulmonary vascular remodeling. J Appl Physiol 100:564-71
Chen, Yiu-Fai; Feng, Ji-An; Li, Peng et al. (2006) Atrial natriuretic peptide-dependent modulation of hypoxia-induced pulmonary vascular remodeling. Life Sci 79:1357-65
Cassina, Patricia; Pehar, Mariana; Vargas, Marcelo R et al. (2005) Astrocyte activation by fibroblast growth factor-1 and motor neuron apoptosis: implications for amyotrophic lateral sclerosis. J Neurochem 93:38-46
Ambalavanan, Namasivayam; Bulger, Arlene; Murphy-Ullrich, Joanne et al. (2005) Endothelin-A receptor blockade prevents and partially reverses neonatal hypoxic pulmonary vascular remodeling. Pediatr Res 57:631-6
Li, Peng; Oparil, Suzanne; Feng, Wenguang et al. (2004) Hypoxia-responsive growth factors upregulate periostin and osteopontin expression via distinct signaling pathways in rat pulmonary arterial smooth muscle cells. J Appl Physiol 97:1550-8; discussion 1549

Showing the most recent 10 out of 51 publications